Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4B |
| 2 |
TC Energy
TRP
|
+$1.99B |
| 3 |
Amazon
AMZN
|
+$1.97B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.83B |
| 5 |
NVIDIA
NVDA
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.57B |
| 2 |
Scotiabank
BNS
|
+$1.51B |
| 3 |
Enbridge
ENB
|
+$1.47B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.02B |
| 5 |
Medtronic
MDT
|
+$871M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 9.2% |
| 3 | Consumer Discretionary | 8.28% |
| 4 | Communication Services | 6.4% |
| 5 | Healthcare | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.61B
| $4.46M | ﹤0.01% |
38,171
+14,388
| +60% | +$1.63M |
|
3727
Vanguard Consumer Discretionary ETF
VCR
$6.33B
| $4.45M | ﹤0.01% |
11,235
-55
| -0.5% | -$20.9K |
|
3728
Nuvation Bio
NUVB
$2.32B
| $4.45M | ﹤0.01% |
1,202,616
-275,428
| -19% | -$751K |
|
3729
Conduent
CNDT
$264M
| $4.45M | ﹤0.01% |
1,589,075
-460,099
| -22% | -$1.25M |
|
3730
CALL
lululemon athletica
LULU
$14.6B
| $4.45M | ﹤0.01% |
25,000
| – | – |
|
3731
Schwab 1000 Index ETF
SCHK
$5.92B
| $4.44M | ﹤0.01% |
138,364
-282,746
| -67% | -$8.75M |
|
3732
PUT
PG&E
PCG
$38.5B
| $4.44M | ﹤0.01% |
294,600
| – | – |
|
|
TVA
3733
Texas Ventures Acquisition III Corp
TVA
$316M
| $4.44M | ﹤0.01% |
+414,306
| New | +$4.21M |
|
|
LINE
3734
Lineage Inc
LINE
$9.65B
| $4.43M | ﹤0.01% |
114,718
-120,060
| -51% | -$4.99M |
|
3735
ALPS Sector Dividend Dogs ETF
SDOG
$1.43B
| $4.43M | ﹤0.01% |
73,586
-1,746
| -2% | -$103K |
|
3736
Playtika
PLTK
$1.12B
| $4.43M | ﹤0.01% |
1,137,655
+752,223
| +195% | +$3.07M |
|
|
PBPB
3737
DELISTED
Potbelly
PBPB
| $4.42M | ﹤0.01% |
259,584
+198,464
| +325% | +$2.69M |
|
|
KCHV
3738
Kochav Defense Acquisition Corp
KCHV
$357M
| $4.42M | ﹤0.01% |
+440,620
| New | +$4.42M |
|
|
DQ
3739
PUT
Daqo New Energy
DQ
$996M
| $4.42M | ﹤0.01% |
+157,100
| New | +$3.68M |
|
|
CIM
3740
Chimera Investment
CIM
$1B
| $4.41M | ﹤0.01% |
333,869
+177,456
| +113% | +$2.47M |
|
3741
RPC Inc
RES
$1.3B
| $4.41M | ﹤0.01% |
926,287
+372,308
| +67% | +$1.76M |
|
|
XIFR
3742
XPLR Infrastructure LP
XIFR
$1.08B
| $4.4M | ﹤0.01% |
432,694
+319,032
| +281% | +$3.09M |
|
3743
Nektar Therapeutics
NKTR
$2.58B
| $4.38M | ﹤0.01% |
77,055
+14,605
| +23% | +$483K |
|
3744
Lindblad Expeditions
LIND
$2.22B
| $4.38M | ﹤0.01% |
342,029
+174,376
| +104% | +$2.3M |
|
|
OSG
3745
Octave Specialty Group
OSG
$222M
| $4.38M | ﹤0.01% |
524,890
+45,507
| +9% | +$384K |
|
3746
WisdomTree US High Dividend Fund
DHS
$1.58B
| $4.37M | ﹤0.01% |
43,410
+12,290
| +39% | +$1.22M |
|
|
AAM
3747
DELISTED
AA Mission Acquisition Corp
AAM
| $4.36M | ﹤0.01% |
414,782
| – | – |
|
3748
dLocal
DLO
$4.24B
| $4.36M | ﹤0.01% |
305,392
-72,698
| -19% | -$924K |
|
|
FACT
3749
FACT II Acquisition Corp
FACT
$260M
| $4.36M | ﹤0.01% |
422,360
| – | – |
|
3750
CALL
iQIYI
IQ
$1.28B
| $4.35M | ﹤0.01% |
+1,700,000
| New | +$3.76M |
|
Similar funds
Goldman Sachs's Q3 2025 Portfolio in Review
As of Q3 2025, Goldman Sachs held 6,765 positions worth $817B, up 11% from $736B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Goldman Sachs's Q3 2025 filing shows 707 new, 2,950 increased, 2,106 reduced and 470 closed positions. Its largest new stake was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M. The largest sale was iShares Russell 2000 ETF, an estimated $1.57B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q3 2025 buy was Fidelity Enhanced International ETF: 1,911,687 shares worth $67.4M.
- Goldman Sachs added most to Microsoft in Q3 2025, an estimated $4B increase.
- Goldman Sachs's biggest Q3 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $1.57B.
- Goldman Sachs fully exited Ansys in Q3 2025, selling an estimated $564M.
- Goldman Sachs's ten largest holdings make up 22% of its $817B portfolio in Q3 2025.
- Goldman Sachs opened 707 new positions and closed 470 in Q3 2025.
- Goldman Sachs's portfolio value rose 11% quarter-over-quarter to $817B.
Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.